Atherotech, Developer of VAP Cholesterol Test, to Present At Salomon Smith Barney Health Care Conference.Business Editors & Health/Medical Writers NEW YORK--(BUSINESS WIRE)--Oct. 28, 2002 Atherotech, Inc., a leading cardiodiagnostic company and specialty reference laboratory, today announced that it will present at the Salomon Smith Barney Smith Barney is a division of Citigroup Global Capital Markets Inc., a global, full-service financial firm, that provides brokerage, investment banking and asset management services to corporations, governments and individuals around the world. Health Care Conference Tuesday, Oct. 29, 2002, at 2 p.m. EST. The presentation will be made by Roseanne Varner, Atherotech's president and chief executive officer. The Salomon Smith Barney Health Care Conference runs Oct. 28-30 at The Plaza hotel The Plaza Hotel in New York City is a landmark 19-story luxury hotel with a height of 250 feet (76 m) and length of 400 feet that (122 m) occupies the west side of Grand Army Plaza, from which it derives its name, and extends along Central Park South in Manhattan. in New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of . Varner will provide an overview of the company and market and discuss the importance and growing acceptance in the medical community of the company's VAP (Value Added Process) An executable program in a NetWare 2.x server. Starting with NetWare 3.x, VAPs were replaced by NLMs. See NetWare. (TM) (Vertical Auto Profile) Cholesterol Test Cholesterol Test Definition The cholesterol test is a quantitative analysis of the cholesterol levels in a sample of the patient's blood. Total serum cholesterol (TC) is the measurement routinely taken. , which detects twice the number of patients at risk for heart disease than the routine cholesterol test. The VAP Test complies with updated National Cholesterol Education Program The National Cholesterol Education Program is a program managed by the National Heart, Lung and Blood Institute, a division of the National Institutes of Health. Its goal is to reduce increased cardiovascular disease rates due to hypercholesterolemia (elevated cholesterol (NCEP NCEP National Cholesterol Education Program ) guidelines, which call for improved patient identification and more aggressive treatment of heart disease. According to Varner, the invitation to this year's conference is an honor for Atherotech and reflects the company's increasing presence in the cholesterol testing market and the emergence of the VAP Test as the new standard of care in cholesterol risk assessment. "Atherotech has experienced enormous growth over the past two years. Our participation in this year's conference demonstrates recognition of the importance of the VAP Test in the early diagnosis and treatment of heart disease -- our nation's No. 1 killer." Birmingham, Ala.-based Atherotech is dedicated to improving the prevention, early diagnosis, and treatment of heart disease and other cardiovascular diseases that kill nearly 1 million Americans each year. The VAP Test provides direct, detailed measurements of cholesterol, or lipid, subclasses that play important roles in the development of heart disease but are not measured by routine cholesterol tests, allowing physicians to improve risk detection and develop patient-specific treatment plans. For more information, visit the company's Web site at www.atherotech.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion